{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (8S,9R,10S,11S,13S,14S,17R)-17-ethylsulfanyl-9-fluoro-11-hydroxy-10,13-dimethyl-17-methylsulfanyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| image = 
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 85197-77-9
| CAS_supplemental = 
| class = [[Corticosteroid]]; [[Glucocorticoid]]
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 6917939
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 5293158
| UNII = 169D68E13P
| KEGG = D06161
| ChEBI = 
| ChEMBL = 1908322

<!--Chemical data-->
| C=22 | H=31 | F=1 | O=2 | S=2
| molecular_weight = 410.606 g/mol
| SMILES = CCS[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)SC
| StdInChI_Ref = 
| StdInChI = 1S/C22H31FO2S2/c1-5-27-21(26-4)11-9-16-17-7-6-14-12-15(24)8-10-19(14,2)22(17,23)18(25)13-20(16,21)3/h8,10,12,16-18,25H,5-7,9,11,13H2,1-4H3/t16-,17-,18-,19-,20-,21+,22-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = DXEXNWDGDYUITL-FXSSSKFRSA-N
| synonyms = SQ-27239; 17α-(Ethylthio)-9α-fluoro-11β-hydroxy-20-thiapregn-1,4-diene-3-one; 17α-(Ethylthio)-9α-fluoro-11β-hydroxy-17-(methylthio)androsta-1,4-dien-3-one
}}

'''Tipredane''' (developmental code name '''SQ-27239''') is a [[synthetic compound|synthetic]] [[glucocorticoid]] [[corticosteroid]] which was never marketed.<ref name="RainsfordVelo2012">{{cite book|author1=Kim D. Rainsford|author2=G. P. Velo|title=New Developments in Antirheumatic Therapy|url=https://books.google.com/books?id=2Cn0CAAAQBAJ&pg=PA154|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-009-1253-3|pages=154,164}}</ref><ref name="KortingSchafer-Korting1998">{{cite book|author1=Hans C. Korting|author2=M. Schafer-Korting|title=The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs|url=https://books.google.com/books?id=t2LUoBonn-cC&pg=PA363|date=24 July 1998|publisher=CRC Press|isbn=978-1-4398-0591-6|pages=363–}}</ref>

==References==
{{Reflist|2}}


{{Glucocorticoid receptor modulators}}

[[Category:Alcohols]]
[[Category:Fluoroarenes]]
[[Category:Glucocorticoids]]
[[Category:Ketones]]
[[Category:Organosulfur compounds]]
[[Category:Pregnanes]]


{{steroid-stub}}